Posts Tagged :

Education & Development

NASP 2025 Annual Meeting & Expo: Location, Dates, What to Expect, and What’s Happening 150 150 Shields Health Solutions

NASP 2025 Annual Meeting & Expo: Location, Dates, What to Expect, and What’s Happening

Each year, NASP members, industry thought leaders, and healthcare veterans from around the country come together to shape the future of specialty pharmacy and the patient journey. Join us to…

Artificial Intelligence in Specialty Pharmacy: Innovation That Empowers, Not Replaces 70 70 Shields Health Solutions

Artificial Intelligence in Specialty Pharmacy: Innovation That Empowers, Not Replaces

Will AI replace pharmacists and technicians? It’s a question that has sparked both curiosity and concern across the healthcare landscape, and understandably so, as artificial intelligence (AI) has already had…

Unlocking the Full Potential of Your DIY Specialty Pharmacy Program: Why Strategic Partnership Matters 70 70 Shields Health Solutions

Unlocking the Full Potential of Your DIY Specialty Pharmacy Program: Why Strategic Partnership Matters

Specialty pharmacy is one of the fastest-growing and most essential parts of today’s healthcare landscape — and you’re likely already feeling both the opportunity and the pressure. As the number…

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy 70 70 Shields Health Solutions

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy

This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy 70 70 Shields Health Solutions

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy

  According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…

Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutions 70 70 Shields Health Solutions

Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutions

Whether through social media, traditional news outlets, or word of mouth, discussions about GLP-1 therapy are everywhere. These medications, originally approved by the FDA for the treatment of Type 2…

Asembia Specialty Pharmacy Summit: Location, Dates, What to Expect, and What’s Happening 70 70 Shields Health Solutions

Asembia Specialty Pharmacy Summit: Location, Dates, What to Expect, and What’s Happening

Every year, more than 8,000 professionals and over 1,400 companies attend the leading specialty pharmacy conference in the nation, Asembia Summit 2024 marked its 20th anniversary — and we couldn’t be…

Shields Outcomes 2024 Report 70 70 Shields Health Solutions

Shields Outcomes 2024 Report

This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients 204 115 Shields Health Solutions

How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients

This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
How Spartanburg Regional Healthcare System Increased Patient Satisfaction by 24% with Specialty Pharmacy Services 204 115 Shields Health Solutions

How Spartanburg Regional Healthcare System Increased Patient Satisfaction by 24% with Specialty Pharmacy Services

This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.